FindTrial
Sign In

To see which of the two nasal treatments works better in frozen shoulder

A randomised comparative clinical study to evaluate the efficacy of marsha nasya with Nirgundi taila and Parinnatakeriksheeradi taila in Apabahuka w.s.r. Adhesive Capsulitis. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/03/106439
Enrollment
280
Registered
2026-03-17
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M953- Acquired deformity of neck

Interventions

None listed

Sponsors

Dr Padmaja P Deshpande
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1Subjects presenting with classical clinical features of Avabahuka 2Subjects with chronicity of disease pertaining from 3 months to 3 years. 3 Subjects between the age group of 18-60 years irrespective of gender. 4Subjects fit for Nasya. 5Diabetic patients whose blood sugar levels are under control.

Exclusion criteria

Exclusion criteria: Apabahuka patients suffering from 1Autoimmune disorders like SLE, RA 2 Respiratory disorders like Bronchial asthma, Allergic bronchitis 3Post Traumatic injuries, Dislocation of Shoulder joint. 4Pregnant and lactating women 5Cervical spondylitis

Design outcomes

Primary

MeasureTime frame
To evaluate and compare the therapeutic effect of Nirgundi Taila Nasya and Parinata Keraksheeradi Taila Nasya in the management of Avabahuka, based on improvement in clinical symptoms and functional parameters.Timepoint: study duration 27days follow up on eighteen and twenty seventh day—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactDr Padmaja P Deshpande

SJG ayurvedic medical college PGstudies research centre and hospital

sureshhakkandi@gmail.com9448609362

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026